Initial Management of Ureteric and Renal Calculi
For patients with ureteric or renal calculi, initial management depends on stone size, location, and symptom severity: stones <10mm with controlled symptoms should receive NSAIDs for pain control plus alpha-blocker medical expulsive therapy, while stones >10mm typically require surgical intervention with ureteroscopy or shock-wave lithotripsy. 1, 2
Pain Management (First Priority)
- NSAIDs (diclofenac, ibuprofen, metamizole) are first-line analgesics for renal colic due to superior efficacy and fewer side effects compared to opioids 1
- Use the lowest effective dose to minimize cardiovascular and gastrointestinal risks 1
- Opioids should only be used as second-line therapy when NSAIDs are contraindicated or insufficient 1
- Pain medications should be taken on a regular schedule rather than "as needed" for optimal control 1
Conservative Management (Stones <10mm)
Patient selection criteria for observation or medical expulsive therapy:
Medical Expulsive Therapy (MET):
- Alpha-blockers (tamsulosin, terazosin, doxazosin) should be prescribed for stones <10mm to facilitate spontaneous passage 1, 3
- MET increases stone passage rates by 29% (77.3% vs 54.4% with placebo for distal stones) and reduces stone passage time 1, 2
- Most stones that pass spontaneously do so within approximately 17 days (range 6-29 days) 1
- Patients must be informed that alpha-blockers are used "off-label" for this purpose and counseled about potential side effects 1
Surgical Intervention (Stones >10mm or Failed Conservative Management)
Both shock-wave lithotripsy (SWL) and ureteroscopy (URS) are acceptable first-line surgical treatments: 1, 2
Ureteroscopy (URS):
- Yields significantly greater stone-free rates with a single procedure but has slightly higher complication rates 1, 2
- Stone-free rates: 81-94% depending on location 4
- Flexible URS for proximal stones: 87% success rate 4
- Rigid/semirigid URS for distal stones: 94% success rate 4
- Complication rates: stricture formation 1-4%, sepsis 2-4%, ureteral perforation <5% 4
Shock-Wave Lithotripsy (SWL):
- Less invasive but may require additional procedures 1
- Stone-free rates: 82% proximal ureter, 73% mid ureter, 74% distal ureter 3
- Additional procedures needed: 0.62 per patient (proximal), 0.52 (mid), 0.37 (distal) 3
- Can be performed with minimal anesthesia, making it attractive for patients who desire treatment without general anesthesia 3
- Serious complications are infrequent 3
Critical caveat: Blind basketing (stone extraction without endoscopic visualization) should never be performed due to high risk of ureteral injury 1, 4
Preoperative Evaluation
Before any surgical intervention:
- Obtain non-contrast CT scan to define exact stone location and degree of hydronephrosis 2, 4
- Perform urinalysis and urine culture to rule out infection 2, 4
- Assess for clinical sepsis 4
- Evaluate renal functional reserve 4
Follow-Up and Monitoring
- Schedule periodic imaging (preferably low-dose CT or ultrasound) to monitor stone position and assess for hydronephrosis 1
- Follow up with urologist within 2-4 weeks if stone has not passed 1
- Complete metabolic testing if indicated (first-time stone formers should have stone analysis performed) 1
Immediate Return to Care Indications
Patients must return immediately if:
- Uncontrolled pain despite adequate analgesia 1
- Fever, chills, or other signs of infection develop 1
- Development of obstruction or worsening hydronephrosis 1
- Anuria (complete cessation of urine output) 1
Special Populations
Pregnancy:
- Renal colic is the most common nonobstetric cause of abdominal pain requiring hospitalization in pregnant patients 3
- Evaluation begins with ultrasonography to limit ionizing radiation 3
- URS has been successfully performed in pregnant patients with very low morbidity 3
- Holmium laser has the advantage of minimal tissue penetration, theoretically limiting risk of fetal injury 3
Pediatric patients:
- SWL outcomes are similar to adults, making it a useful option particularly when patient size may make URS less attractive 3